comparemela.com
Home
Live Updates
IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S : comparemela.com
IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S
Presenting details on initial response data from the ongoing VITALIZE DLBCL trial at the Immuno-Oncology 360° conference on February 10, 2023
Expects preliminary clinical response data from the... | January 8, 2023
Related Keywords
New York ,
United States ,
Andrew Hall ,
Michael Bailey ,
Bristol Myers Squibb ,
Shabnam Kazmi ,
Juliap Gregory ,
Harvard Business School ,
Linkedin ,
Smith College ,
Twitter ,
Otsuka America Pharmaceuticals ,
Nasdaq ,
Board Member Of The Prevent Cancer Foundation ,
Ovarian Cancer ,
Chief Executive Officer ,
Diffuse Largeb Cell Lymphoma ,
New York City ,
Otsuka America ,
Asellus Ventures ,
Board Member ,
Prevent Cancer ,
Harvard Business ,
Board Chairman ,
Imv Inc Stock Exchange ,
News ,
Information ,
Press Release ,
Resenting ,
Details ,
N ,
Nitial ,
Response ,
Data ,
Rom ,
The ,
Ngoing ,
Revitalize ,
Dlbcl ,
Trial ,
It ,
Conference ,
February ,
Reliminary ,
Linical ,
Rom Imv Ca44974l3011 ,
comparemela.com © 2020. All Rights Reserved.